Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 15, 2014

Big Pharma Issues and Strategy in a Single Visual

The historical graph that tells many stories.

Big Pharma Issues and Strategy in a Single Visual

Discounted discovery and development cost and discounted income (vertical or y-axis) for one-hundred drug candidates that entered clinical trials at year -8 (horizontal or x-axis).

  • This article is aimed at those interested in learning about the drug discovery and development (DD&D) business, who include science Ph.D.s and business people ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »